PubMed=1965684
Yoshida K., Tomizawa H., Ota T., Nagashima T., Kikuchi H., Watanabe H., Hashizaki K., Yonaha A.
Establishment and characterization of human cholangiocarcinoma, MEC, producing carbohydrate antigen 19-9.
Hum. Cell 3:346-351(1990)

PubMed=21451941; DOI=10.1007/s00534-011-0376-7
Sato J., Kimura T., Saito T., Anazawa T., Kenjo A., Sato Y., Tsuchiya T., Gotoh M.
Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma.
J. Hepatobiliary Pancreat. Sci. 18:700-711(2011)

CLPUB00275
Zach S., Birgin E., Ruckert F.
Primary cholangiocellular carcinoma cell lines.
J. Stem Cell Res. Transplant. 2:1013-1013(2015)

PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007
Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y., Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S., Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.
Development and characterization of human primary cholangiocarcinoma cell lines.
Am. J. Pathol. 192:1200-1217(2022)

PubMed=36724073; DOI=10.1016/j.celrep.2023.112065
Yang J.-C., Guo F.-S., Chin H.-S., Chen G.-B., Ang C.-H., Lin Q.-S., Hong W.-J., Fu N.-Y.
Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins.
Cell Rep. 42:112065.1-112065.26(2023)